 Health Newstrack | Anemia treatment not beneficial in heart failure Family Practice News Digital Network SAN FRANCISCO – Treatment of anemic heart failure patients with the erythropoiesis-stimulating agent darbepoetin alfa failed to produce any clinically meaningful improvements and significantly raised the incidence of ischemic stroke and thrombotic ... Aarbepoetin alfa does not improve anemic heart failure patients' health Yet Another Negative Trial For Amgen's Aranesp |
